Donor Variability and 3D Culture Models Influence Human Mesenchymal Stem Cell Differentiation
Tissue Engineering Part A · 2026
DOI: 10.1089/ten.tea.2025.0028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tissue Engineering Part A, 2026. Verfasst von Sarah Jones und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Cell Differentiation, Cell Culture Techniques, Three Dimensional, Cell Culture Techniques. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIAMS NIH HHS, NIDCR NIH HHS.
Abstract (Originalsprache)
Mesenchymal stem cells (MSCs) are widely used for tissue regeneration due to their multilineage differentiation potential and ability to secrete paracrine factors with immunomodulatory and angiogenic functions. Standard MSC differentiation protocols typically rely on two-dimensional (2D) or pellet culture models that are simple to use but not well-suited for translational or clinical applications. To promote better cell survival, tissue deposition, and differentiation of MSCs, a wide variety of three-dimensional (3D) biomaterial scaffolds and platforms have been developed that provide structural support and present a carefully defined set of biochemical and biophysical cues to cells. While biomaterials can guide cell behavior and promote desirable tissue regeneration outcomes, one remaining challenge in the field is inherent donor-to-donor variability in MSC behavior, phenotype, and differentiation capacity. Although MSCs are promising tools for regeneration, the influence of donor variability on MSC differentiation across culture models remains poorly understood. Previous studies typically use cells from a single donor or rely solely on standard culture models. To address these gaps, we compared MSCs from six human donors and assessed differentiation across chondrogenic, osteogenic, and adipogenic lineages using both standard (pellet or 2D) and 3D biomaterial-based culture models. Alginate hydrogels were used to assess chondrogenesis, while gelatin microribbon (µRB) hydrogels were used to evaluate osteogenesis and adipogenesis in 3D. Significant donor-to-donor variability was observed in differentiation outcomes across all three lineages and within both 2D and 3D culture models. By directly comparing donor variability in 2D and 3D, we provide evidence that standard 2D models cannot predict MSC differentiation capacity in 3D biomaterials. Therefore, to improve therapeutic efficacy and advance biomaterial-based strategies for tissue regeneration, it is critical to understand how donor variability affects MSC differentiation patterns across 3D biomaterial-based culture models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Stanford University, Stanford, California, USA.
- Department of Bioengineering, Stanford University, Stanford, California, USA.
- Department of Biology, Stanford University, Stanford, California, USA.
- Department of Orthopaedic Surgery, Stanford University School of Medicine, Stanford, California, USA.
ORCID-Profile: Sarah Jones, Michelle Tai, Julia Johannsen
Förderung
- NIAID NIH HHS
- NIAMS NIH HHS
- NIDCR NIH HHS
Zitieren
APA
Jones, S., Tai, M., Ayushman, M., Peasah, A., Johannsen, J., & Yang, F. (2026). Donor Variability and 3D Culture Models Influence Human Mesenchymal Stem Cell Differentiation. Tissue Engineering Part A. https://doi.org/10.1089/ten.tea.2025.0028
Vancouver
Jones S, Tai M, Ayushman M, Peasah A, Johannsen J, Yang F. Donor Variability and 3D Culture Models Influence Human Mesenchymal Stem Cell Differentiation. Tissue Engineering Part A. 2026. doi:10.1089/ten.tea.2025.0028
BibTeX
@article{Jones2026,
author = {Jones, Sarah and Tai, Michelle and Ayushman, Manish and Peasah, Abena and Johannsen, Julia and Yang, Fan},
title = {Donor Variability and 3D Culture Models Influence Human Mesenchymal Stem Cell Differentiation},
journal = {Tissue Engineering Part A},
year = {2026},
doi = {10.1089/ten.tea.2025.0028}
}
EUVIMED